US Patent 7527793 Immunogenic peptides
Patent 7527793 was granted and assigned to Rush University Medical Center (company) on May, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+420 characters)
Article
Patent abstract
The invention provides relatively short immunogenic peptides, and biologically active variants thereof, associated with leukemia which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07527793 Immunogenic peptides US Patent 7527793 Immunogenic peptides
Infobox
Patent Number
0752779300
Patent Number
752779300
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075277930
Date of Patent
May 5, 2009
0Patent Application Number
104283350
Date Filed
May 2, 2003
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075277930
Date of Patent
May 5, 2009
0Patent Application Number
104283350
Date Filed
May 2, 2003
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07527793 Immunogenic peptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07527793
Date of patent
May 5, 2009
Patent application number
10428335
Date Filed
May 2, 2003
Patent primary examiner
Find more entities like US Patent 7527793 Immunogenic peptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
